Evolution of the Average Target: Cerence Inc.

Evolution of the Average Target - Cerence Inc.

Evolution of the Target Price: Cerence Inc.

Evolution of the Target Price - Cerence Inc.

Changes in Analyst Recommendations: Cerence Inc.

eda.QlCoZuZO9XaRymJMeAGGM-AQl2hvm0HF7NtQTNSHsk8.BGHkDK15hgKlvjIFCXPDW6NB5QMO-hKdr7Aff53S3gUHYco0vH-yO6KzDQ~0602ade1ea0b88309af104ac245b4a32
04-02 Cantor Fitzgerald Initiates Cerence at Overweight With $11 Price Target MT
06/08/25 Cerence Q3 revenue beats expectations RE
22/01/25 Needham Upgrades Cerence to Buy From Hold, $16 Price Target MT
15/07/24 Evercore ISI Adjusts Cerence's Price Target to $5 From $8, Maintains In Line Rating MT
12/07/24 Baird Adjusts Price Target on Cerence to $6 From $8, Maintains Neutral Rating MT
10/05/24 Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating MT
10/05/24 Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating MT
10/05/24 Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50 MT
17/04/24 Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating MT
07/02/24 Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating MT
07/02/24 Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22 MT
29/11/23 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating MT
29/11/23 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept MT
28/11/23 Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating MT
28/11/23 Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating MT
28/11/23 Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating MT
09/08/23 Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating MT
11/05/23 Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating MT
10/05/23 Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating MT
10/02/23 Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating MT
09/02/23 Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating MT
09/02/23 Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating MT
09/02/23 Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating MT
09/02/23 Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating MT
09/02/23 Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+27.52%
+9.82%
-2.73%
+68.3%
-5.22%
-12.68%
+9.89%
+4.17%
-15.63%
-1.85%
Average +8.16%
Weighted average by Cap. +10.08%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
8.430USD
Average target price
10.75USD
Spread / Average Target
+27.52%
High Price Target
12.00USD
Spread / Highest target
+42.35%
Low Price Target
9.000USD
Spread / Lowest Target
+6.76%

Analyst Consensus Detail

Analyst consensus - Cerence Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Cerence Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Ratings Surperformance© - Cerence Inc.
  1. Stock Market
  2. Stocks
  3. CRNC Stock
  4. Consensus Cerence Inc.